2015•Chin J Gastroesophagol Reflux Dis(Electronic Edition)Requires access

Observation of clinical efficacy of esomeprazole in combination of mosapride in the treatment of reflux esophagitis after resection of cardiac carcinoma

Chun Yang

Open publisher page 0 citations

Abstract

Objective To explore the clinical efficacy of esomeprazole in combination of mosapride in the treatment of reflux esophagitis after resection of cardiac carcinoma. Methods 76 patients with reflux esophagitis after resection of cardiac carcinoma were randomized into two group, treatment group and Control group.The treatment group(n=38)received treatment of esomeprazole plus mosapride, and the control group(n=38)received treatment of mosapride only.Improvements of clinical symptoms and endoscoic pathological changes after 8 weeks were observed. Results Clinical efficacy and and endoscope results of treatment group were better than control group, with statistically difference(P<0.05). Conclusion Esomeprazole in combination of mosapride shows more significant clinical efficacy then mosapride only in the treatment of reflux esophagitis after resection of cardiac carcinoma, which is worth a clinical promotion. Key words: Esophagitis, Peptic; Esomeprazole, cardiac carcinoma

About this research paper

What this paper is about

Objective To explore the clinical efficacy of esomeprazole in combination of mosapride in the treatment of reflux esophagitis after resection of cardiac carcinoma. Methods 76 patients with reflux esophagitis after resection of cardiac carcinoma were randomized into two group, treatment group and Control group.The treatment group(n=38)received treatment of esomeprazole plus mosapride, and the control group(n=38)received treatment of mosapride only.Improvements of clinical symptoms and endoscoic pathological changes after 8 weeks were observed. Results Clinical efficacy and and endoscope results of treatment group were better than control group, with statistically difference(P<0.05). Conclusion Esomeprazole in combination of mosapride shows more significant clinical efficacy then mosapride only in the treatment of reflux esophagitis after resection of cardiac carcinoma, which is worth a clinical promotion. Key words: Esophagitis, Peptic; Esomeprazole, cardiac carcinoma

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To explore the clinical efficacy of esomeprazole in combination of mosapride in the treatment of reflux esophagitis after resection of cardiac carcinoma. Methods 76 patients with reflux esophagitis after resection of cardiac carcinoma were randomized into two group, treatment group and Control group.The treatment group(n=38)received treatment of esomeprazole plus mosapride, and the control group(n=38)received treatment of mosapride only.Improvements of clinical symptoms and endoscoic pathological changes after 8 weeks were observed. Results Clinical efficacy and and endoscope results of treatment group were better than control group, with statistically difference(P<0.05). Conclusion Esomeprazole in combination of mosapride shows more significant clinical efficacy then mosapride only in the treatment of reflux esophagitis after resection of cardiac carcinoma, which is worth a clinical promotion. Key words: Esophagitis, Peptic; Esomeprazole, cardiac carcinoma

Key concepts: Mosapride, Esomeprazole, Medicine, Reflux esophagitis, Gastroenterology, Internal medicine, Reflux, Esophagitis

Related papers

Back to paper searchBrowse research topicsOriginal source
Observation of clinical efficacy of esomeprazole in combination of mosapride in the treatment of reflux esophagitis after resection of cardiac carcinoma — Research Paper | ScholarLens